Related Experiment Video

Updated: Jul 14, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

[Relevance of microRNA-s in neoplastic diseases]

Zsófia Tömböl1, Péter Szabó, Károly Rácz

  • 1Semmelweis Egyetem, Altalános Orvostudományi Kar II. Belgyógyászati Klinika, Budapest.

Orvosi Hetilap
|June 15, 2007
PubMed

Insights

MicroRNAs, small RNA molecules, regulate gene expression and are implicated in various diseases, particularly cancers. Their distinct expression patterns offer diagnostic potential and future therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Context:

  • MicroRNAs (miRNAs) are endogenous small RNA molecules (19-23 nucleotides) that act as key regulators in RNA interference pathways.
  • They modulate gene expression by inhibiting messenger RNA (mRNA) translation or promoting mRNA degradation.
  • Altered miRNA expression is a hallmark of numerous human diseases, with extensive research focusing on their role in neoplasms.

Purpose:

  • To review the role of microRNAs in physiological and pathophysiological processes.
  • To highlight the significance of altered miRNA expression profiles in various human diseases, especially cancers.
  • To explore the diagnostic and potential therapeutic applications of miRNAs in oncology and other diseases.

Summary:

  • MicroRNAs are crucial regulators of gene expression with significant roles in both normal physiology and disease pathogenesis.
  • Aberrant miRNA expression profiles are characteristic of various malignancies, including solid tumors and hematologic cancers.
  • Specific miRNA signatures can differentiate between benign and malignant thyroid neoplasms and correlate with the clinical behavior of lung tumors and chronic lymphocytic leukemia.

Impact:

  • MicroRNA profiling provides a novel tool for cancer diagnosis and classification, aiding in distinguishing benign from malignant conditions.
  • Understanding miRNA dysregulation in diseases like cancer opens avenues for developing targeted miRNA-based therapies.
  • Future research may leverage small RNA molecules for therapeutic interventions, offering new treatment strategies for various human diseases.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...